|
Time |
Title |
Presenter |
|
6:30 a.m. |
Registration/Continental Breakfast/Exhibits |
|
7:00 - 9:10 a.m. |
Neuromodulation: Chemicals, Currents and Extreme Temperatures…What Works and What Doesn’t |
Moderator: Paul S. Cederna, MD, FACS
|
|
7:00 a.m. |
Traditional Neurotoxins: New Applications |
Steven Fagien, MD, FACS
|
|
7:15 a.m. |
Topical Neurotoxin: Current Status |
Richard G. Glogau, MD |
|
7:30 a.m. |
Discussion |
Paul S. Cederna, MD, FACS |
|
7:40 a.m. |
Radiofrequency Ablation of Nerves |
Gregory Borschel, MD, FACS, FAAP |
|
7:55 a.m. |
Radiofrequency Nerve Stimulation |
Gregory Borschel, MD, FACS, FAAP |
|
8:10 a.m. |
Neuromodulation Surgery for Control of Migraine and Cluster Headaches |
Frank A. Papay, MD |
|
8:20 a.m. |
Discussion |
Paul S. Cederna, MD, FACS |
|
8:30 a.m. |
Allergan Perspective: What's Available and What's on the Horizon |
Conor Gallagher, PhD |
|
8:45a.m. |
Merz Perspective: What's Available and What's on the Horizon |
Bhushan Hardas, MD, MBA |
|
8:55 a.m. |
Discussion
|
Paul S. Cederna, MD, FACS
|
|
9:10 - 9:40 a.m. |
Break/Exhibits |
|
9:40 - 11:50 a.m. |
ADM for Breast Reconstruction is it Worth the Price?
|
Charles E. Butler, MD, FACS
|
|
9:40 a.m. |
Perspective of ADM Routine User |
Patrick B. Garvey, MD, FACS
|
|
9:50 a.m. |
Perspective of ADM Non-User |
Randy Sherman, MD, FACS
|
|
10:00 a.m. |
Discussion and Q & A |
Charles E. Butler, MD, FACS
|
|
10:20 a.m. |
Industry Perspective with Bard/Davol (ALLOMAX™) |
Devang V. Shah, PhD |
|
10:30 a.m. |
Industry Perspective with MTF (Flex HD/Dermamatrix) |
Mark Spilker, PhD |
|
10:40 a.m. |
Industry Perspective with Life Cell (AlloDerm®) |
Michael G. Franz, MD, FACS
|
|
10:50 a.m. |
Discussion and Q & A |
Charles E. Butler, MD, FACS
|
|
11:10 a.m. |
FDA and Economic Perspective |
Janette Alexander, MD
|
|
11:20 a.m. |
Financial Analysis |
David Song, MD, MBA |
|
11:30 a.m. |
Discussion and Q & A |
Charles E. Butler, MD, FACS |
|
11:50 a.m. |
Adjourn |